Skye Bioscience Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| 5AM VENTURE MANAGEMENT, LLC | 08/14/2026 | 9.68 M | $6.71 M | 0.00% | 24.40% |
| VERSANT VENTURE MANAGEMENT, LLC | 08/12/2026 | 2.01 M | $1.39 M | 0.00% | 5.06% |
| BAKER BROS. ADVISORS LP | 08/14/2026 | 1.58 M | $1.09 M | 0.00% | 3.97% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 763.88 K | $529.37 K | -0.08% | 1.93% |
| SPHERA FUNDS MANAGEMENT LTD. | 08/14/2026 | 678.93 K | $470.70 K | 0.00% | 1.71% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 08/13/2026 | 233.10 K | $161.61 K | 0.00% | 0.59% |
| BLACKROCK, INC. | 08/07/2026 | 232.87 K | $161.45 K | -18.61% | 0.59% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 218.06 K | $151.23 K | -21.35% | 0.55% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 198.52 K | $137.64 K | -23.11% | 0.50% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 104.23 K | $72.23 K | 0.00% | 0.26% |
| CITADEL ADVISORS LLC | 09/02/2026 | 88.60 K | $61.43 K | 126.60% | 0.22% |
| STATE STREET CORP | 08/07/2026 | 73.83 K | $51.19 K | -1.99% | 0.19% |
| UBS GROUP AG | 08/13/2026 | 73.80 K | $51.14 K | 61.27% | 0.19% |
| NORTHERN TRUST CORP | 08/13/2026 | 56.33 K | $39.05 K | 179.65% | 0.14% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2026 | 43.08 K | $29.87 K | 100.00% | 0.11% |
| CITADEL ADVISORS LLC | 09/02/2026 | 35.40 K | $24.54 K | -40.80% | 0.09% |
| SIMPLEX TRADING, LLC | 08/12/2026 | 26.98 K | $18.70 K | 100.00% | 0.07% |
| XTX TOPCO LTD | 08/14/2026 | 20.99 K | $14.55 K | -48.70% | 0.05% |
| ENGINEERS GATE MANAGER LP | 08/14/2026 | 20.19 K | $14.00 K | 0.00% | 0.05% |
| GROUP ONE TRADING, L.P. | 08/14/2026 | 4.59 K | $3.18 K | -36.31% | 0.01% |
| VANGUARD GLOBAL ADVISERS, LLC | 08/13/2026 | 4.56 K | $3.16 K | 0.00% | 0.01% |
| MERCER GLOBAL ADVISORS INC /ADV | 08/11/2026 | 3.07 K | $2.13 K | 100.00% | 0.01% |
| MORGAN STANLEY | 08/13/2026 | 2.47 K | $1.71 K | -3.14% | 0.01% |
| BARCLAYS PLC | 08/14/2026 | 655 | $455 | -96.38% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 600 | $413 | 0.00% | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 08/10/2026 | 400 | $275 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2026 | 66 | $44 | 0.00% | 0.00% |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 08/12/2026 | 52 | $36 | 0.00% | 0.00% |
| TD WATERHOUSE CANADA INC. | 07/27/2026 | 52 | $35 | -34.18% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 08/14/2026 | 51 | $35 | 0.00% | 0.00% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 08/13/2026 | 39 | $27 | 0.00% | 0.00% |
| OPTIVER HOLDING B.V. | 08/12/2026 | 20 | $14 | 0.00% | 0.00% |
| CORECAP ADVISORS, LLC | 07/06/2026 | 8 | $6 | 0.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 08/14/2026 | 8 | $5 | 100.00% | 0.00% |
| GILPIN WEALTH MANAGEMENT, LLC | 07/24/2026 | 4 | $3 | 100.00% | 0.00% |
| PLANTE MORAN FINANCIAL ADVISORS, LLC | 08/06/2026 | 3 | $2 | 0.00% | 0.00% |
| INTEGRATED WEALTH CONCEPTS LLC | 08/12/2026 | 2 | $2 | 100.00% | 0.00% |
| MCGUIRE CAPITAL ADVISORS INC | 08/14/2026 | 2 | $1 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 1 | $1 | 100.00% | 0.00% |
| FMR LLC | 08/13/2026 | 1 | $1 | 100.00% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 08/12/2026 | 1 | $1 | 0.00% | 0.00% |
| IFP ADVISORS, INC | 07/20/2026 | 1 | $1 | -50.00% | 0.00% |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 08/14/2026 | 1 | $1 | 0.00% | 0.00% |
| LEO H. EVART, INC. | 08/18/2026 | 1 | $1 | 0.00% | 0.00% |
| PFS PARTNERS, LLC | 07/20/2026 | 1 | $1 | 0.00% | 0.00% |
| CITIGROUP INC | 08/03/2026 | 0 | $0 | -100.00% | 0.00% |
| FEDERATED HERMES, INC. | 08/12/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Skye Bioscience Inc institutional Ownership - FAQ's
During the previous two years, 51 institutional investors and hedge funds held shares of Skye Bioscience Inc. The most heavily invested institutionals were:
5AM Venture Management, LLC: 9.68 M
Versant Venture Management, LLC: 2.01 M
BAKER BROS. ADVISORS LP: 1.58 M
VANGUARD CAPITAL MANAGEMENT LLC: 763,882
SPHERA FUNDS MANAGEMENT LTD.: 678,928
PLATINUM INVESTMENT MANAGEMENT LTD: 233,095
40.39% of Skye Bioscience Inc stock is owned by institutional investors.
Institutional investors have bought a total of 18.77 M shares in the last 24 months. This purchase volume represents approximately $13.52 M in transactions.